Ultragenyx Pharmaceutical Inc (RARE)
40.90
-0.32
(-0.78%)
USD |
NASDAQ |
May 10, 16:00
40.88
-0.02
(-0.04%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Gross Profit (Quarterly): 91.30M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 91.30M |
December 31, 2023 | 115.34M |
September 30, 2023 | 87.06M |
June 30, 2023 | 98.40M |
March 31, 2023 | 88.24M |
December 31, 2022 | 98.03M |
September 30, 2022 | 82.07M |
June 30, 2022 | 81.07M |
March 31, 2022 | 73.84M |
December 31, 2021 | 79.88M |
September 30, 2021 | 77.47M |
June 30, 2021 | 83.84M |
March 31, 2021 | 94.21M |
December 31, 2020 | 86.06M |
September 30, 2020 | 79.12M |
Date | Value |
---|---|
June 30, 2020 | 59.91M |
March 31, 2020 | 39.81M |
December 31, 2019 | 30.49M |
September 30, 2019 | 23.12M |
June 30, 2019 | 23.38M |
March 31, 2019 | 17.72M |
December 31, 2018 | 15.75M |
September 30, 2018 | 11.49M |
June 30, 2018 | 12.65M |
March 31, 2018 | 10.45M |
December 31, 2017 | 2.413M |
September 30, 2017 | 0.198M |
June 30, 2017 | |
March 31, 2017 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
23.12M
Minimum
Sep 2019
115.34M
Maximum
Dec 2023
74.63M
Average
81.57M
Median
Gross Profit (Quarterly) Benchmarks
Corcept Therapeutics Inc | 144.27M |
Madrigal Pharmaceuticals Inc | -- |
Sarepta Therapeutics Inc | 362.90M |
FibroGen Inc | 30.15M |
Rocket Pharmaceuticals Inc | -- |